Deutsche Bank analysts see the deal as a potential catalyst for Lilly's growth.

The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk that would cut the price of obesity drugs to $149 per month in some cases and extend coverage to certain Medica...